Exelixis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Exelixis and other ETFs, options, and stocks.About EXEL
Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic.
EXEL Key Statistics
Stock Snapshot
As of today, Exelixis(EXEL) shares are valued at $50.66. The company's market cap stands at 12.54B, with a P/E ratio of 15.82.
On 2026-08-13, Exelixis(EXEL) stock traded between a low of $49.97 and a high of $51.14. Shares are currently priced at $50.66, which is +1.4% above the low and -0.9% below the high.
The Exelixis(EXEL)'s current trading volume is 1.86M, compared to an average daily volume of 3.4M.
In the last year, Exelixis(EXEL) shares hit a 52-week high of $57.57 and a 52-week low of $33.76.
In the last year, Exelixis(EXEL) shares hit a 52-week high of $57.57 and a 52-week low of $33.76.
EXEL News
...
Image source: The Motley Fool. Wednesday, Aug. 5, 2026 at 5:00 p.m. ET CALL PARTICIPANTS President - Michael Morrissey Chief Financial Officer - Christopher Se...
Exelixis (EXEL) is back in focus after reporting second quarter results that showed higher revenue and net income year on year, while also trimming full year re...
Analyst ratings
57%
of 21 ratingsMore EXEL News
Exelixis ((EXEL)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing tools with TipRan...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.